Member Info for Cashintime

Great stuff this morning as we enter the 9p range. The rise has practically been daily and steady for the last couple of weeks as we await news by the months end , H1

I also think this is the case and if so he must be liable to prosecution if he is running a company this way.

It is high time Silent Steve comes clean about Turkey. These larger perf guns should take no more than a day of googling and sourcing the nearest availablity even for a layman not to mind those involved in the industry. Put them on a container and ship . He is not deserving of his £1000+ a day and never was.

Anabio is right. I am getting mixed up with our AI friends One three. Good momentum this morning.

Great to see one of our other products getting the limelight. I think this is the one that Onebio has been working on this past year.

As per RNS 24 March 2022 first results from Cytoreason AI will be H1 2023.

An agreed work program was started then and we are known for keeping our guilded timelines here. So that news is imminent and red hot with the growing AI sentiment at the moment. Another good day for Poolbeg today.

Ask 8.50p now. Good to see the shareprice getting back towards where it should be. I think people are getting on board for Cytoreason first results.

Was it Dave English that told us that last year 90% of big Pharma deal were completed in H1. If so the next few weeks will tell alot. The fishing line is cast, will we get a bite.

We are all awaiting a partnership deal for our promising flagship product. Our AI collaboration news with Cytoreason is due in H1 so a matter of a few weeks at most but likely very soon. Our news flow has dried up recently compared to almost weekly last year but our next news will be groundbreaking. We are not quiet back at IPO price yet but are showing an upward trend of late. 2023 will be Poolbegs year.

Unbelievable that he can drag this Turkey saga out past this upcoming court case. Silent Steve refuses to announce his failures. Can he just be replaced by somebody who is able to be a proper CEO.

Somebody has being buying a bit of a stake recently.

Great to see us continue the momentum with 8.40p paid for those wanting 100,000 shares.

Remember RNS from 24 Mar 2022 when we first got told of the Cytoreason AI collaboration. We have unique data and they have an unique AI model to investigate and discover new drug targets. First results within 3 weeks but can come at any time. This will be the next big news here and we all know how hot AI is at the moment. Whose interest will we catch when results come out. All the top big Pharma I bet.

" The partnership will bring Poolbeg's unique repository of clinical samples and associated data from influenza human challenge trials together with CytoReason's leading and validated AI technology. This will enable a deep understanding of the mechanism of influenza infection and recovery and, as a result, help identify novel drug targets for the disease. Poolbeg's datasets for influenza are already tailored for incorporation into CytoReason's platform algorithms. Both CytoReason and the Company are excited about the unique and novel disease-relevant insights, which have the potential to transform how influenza is currently treated. The project is due to commence immediately with a full work programme already agreed, and first results expected in H1.

They have an order for a good batch of shares at a premium price if needed. A few chunks have gone through delayed the last couple of days.

Silent Steve is doing what he does best. He has failed miserably to produce any meaningful oil or gas. He is obviously not CEO material and is suitable only for working in a background role. He has performed so badly and wasted so much money that he deserves the cessation of his contact. He has squirreled away a few million for his nest egg these last few years.

Ask 8.20p, tipping along nicely now.

Some big buying yesterday alright that is moving the price up a bit.

June will be the month that will see a lift in sentiment here. We will get those Cytoreason results and with AI being so hot at the moment and Poolbeg being ahead of the curve we could just become the new darling of the Pharma and BioTech world.

A Polb 001 deal will be life changing for some here as it could be a blockbuster with possible $300m+ deal in the longterm

We are about to enter the last month of Q2 so we eagerly await Cytoreason results which can come at any time but are not more than 4 weeks away , as we are know for hitting our timelines. These will be interesting as they use our unique data (borrowed from our good buddy's in Hvivo) which nobody has access to.

Cytoreason is now part owned by Pfizer's as they were so impressed there while getting work done that they took I think $100m stake there. They will be aware if the quality of our data is good and is amounting to new identified targets.

Also were we not told that big Pharma data shows that 90% of partnership deals were done in H1 which finishes in a month's time. Maybe we are going to get a deserved deal from one of the biggies that will blow the lid off and multi bag us from these ridiculous lows. We should be at double this current price with all achieved and our growing asset bank. We have a good team behind us and something is stirring in the background me thinks. GLALTHs

7.50p on the ask.

Prof Brendan Buckley is our medical heavy hitter and it is great to have him on board. Of course he is a founder member of Open Orphan. We share office space data and probably the office printer with them. It is in keeping with our capital light model. He has good confidence in our products and will be a great ambassador for them when needed.